What Does Ovid Therapeutics Do?

Total employees41
HeadquartersNew York
Founded2014

Ovid Therapeutics (NASDAQ: OVID) is a New York-based biopharmaceutical company dedicated to the development and commercialization of impactful medicines that transform the lives of patients with rare neurological disorders. The company focuses on targeting the underlying biological pathways of these conditions with precision. Ovid's strategy involves advancing its own pipeline programs and exploring strategic collaborations to bring novel therapies to patients with significant unmet medical needs. Their work is driven by a deep understanding of neuroscience and a commitment to the patient communities they serve.

Where Is Ovid Therapeutics's Headquarters?

HQ Function

Serves as the primary corporate center for Ovid Therapeutics, housing executive leadership, clinical development oversight, research management, business development, financial operations, and investor relations.

Notable Features:

Located in a modern office building in the vibrant Times Square area of Manhattan, offering excellent connectivity and access to New York City's extensive biotech, financial, and talent resources. Specific internal features are designed for a corporate biopharmaceutical setting.

Work Culture:

Ovid Therapeutics likely fosters a dynamic, science-driven, and patient-centric work environment. The culture probably emphasizes collaboration, innovation, urgency in addressing rare diseases, and a strong ethical commitment, typical of biotech firms focused on high unmet medical needs.

HQ Significance:

The New York City headquarters provides strategic access to global financial markets, a rich pool of scientific and business talent, and a dense network of academic institutions and potential partners, crucial for a publicly-traded biopharmaceutical company.

Values Reflected in HQ: The choice of a prominent, central New York City location may reflect Ovid's commitment to being at the forefront of the biopharmaceutical industry, its ambition for growth, and its desire to attract and retain top talent in a competitive field.

Location:

While Ovid Therapeutics is headquartered in the United States, its operations, particularly clinical trials and research collaborations, may extend globally. The company partners with international research institutions and clinical sites to advance the development of therapies for rare neurological diseases, aiming to serve patients worldwide. Their business development activities also engage with potential partners on a global scale.

Street Address:

1460 Broadway, New York

City:

New York

State/Province:

NY

Country:

USA

Where Else Does Ovid Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Ovid Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ovid Therapeutics? Meet the Executive Team

As of April 2025, Ovid Therapeutics' leadership includes:

Jeremy M. Levin, DPhil, MB, BChir - Chairman and Chief Executive Officer
Jeffrey Rona - Chief Business & Financial Officer
Claude Nicaise, M.D. - Head of Research and Development
Manoj Malhotra, EdD - Chief Operating Officer
Annahita Keravala, Ph.D. - Senior Vice President, Head of Translational Medicine & Nonclinical Development
Kevin Fitzgerald, Ph.D. - Senior Vice President, Head of Business Development and Alliance Management
Heidi Crayton, MD - Vice President, Clinical Development & Medical Affairs

Who's Investing in Ovid Therapeutics?

Ovid Therapeutics has been backed by several prominent investors over the years, including:

Deerfield Management Company
T. Rowe Price Associates
RA Capital Management
BlackRock Inc.
The Vanguard Group
Point72 Asset Management

What Leadership Changes Has Ovid Therapeutics Seen Recently?

Hire2
Exits0

Over the last 12-15 months, Ovid Therapeutics has made significant additions to its executive team, appointing a new Chief Operating Officer and a new Head of Research and Development, reflecting its commitment to advancing its pipeline and strengthening operational leadership. No high-profile executive departures were publicly announced during this specific period.

New Appointments:

Manoj Malhotra, EdD, Manoj Malhotra, EdD, appointed as Chief Operating Officer.
Claude Nicaise, M.D., Claude Nicaise, M.D., appointed as Head of Research and Development.

What Technology (Tech Stack) Is Used byOvid Therapeutics?

Discover the tools Ovid Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ovid Therapeutics Email Formats and Examples

Ovid Therapeutics commonly uses the email format combining the first initial of an employee's first name with their full last name, followed by '@ovidrx.com'. This is a standard convention in many corporations.

[first_initial][last]@ovidrx.com

Format

jlevin@ovidrx.com

Example

85%

Success rate

What's the Latest News About Ovid Therapeutics?

Ovid Therapeutics Investor RelationsMay 9, 2024

Ovid Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Ovid Therapeutics announced its financial results for the first quarter ended March 31, 2024, and provided updates on its pipeline programs, including progress on its KIF1A associated neurological disorder (KAND) program and soticlestat development....more

Ovid Therapeutics Investor RelationsMarch 4, 2024

Ovid Therapeutics Appoints Manoj Malhotra, Ed.D., as Chief Operating Officer

Ovid announced the appointment of Manoj Malhotra, Ed.D., as its new Chief Operating Officer. Dr. Malhotra brings extensive experience in biopharmaceutical operations, strategy, and commercialization to the role....more

Ovid Therapeutics Investor RelationsJanuary 4, 2024

Ovid Therapeutics Highlights Key 2023 Accomplishments and Outlines 2024 Strategic Priorities

Ovid Therapeutics provided a summary of its significant achievements throughout 2023, including advancements in its research pipeline and corporate milestones, and detailed its strategic priorities for 2024 focused on developing treatments for rare neurological diseases....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ovid Therapeutics, are just a search away.